Harvard Bioscience (HBIO) Other financing activities (2013 - 2026)
Harvard Bioscience (HBIO) reported Other financing activities of $30000.0 for Q1 2026, down 76.74% year-over-year from $129000.0 in Q1 2025, and down 47.37% on a QoQ basis from $57000.0 in Q4 2025.
Harvard Bioscience (HBIO) has 11 years of Other financing activities data on file, last reported at $30000.0 in Q1 2026.
- Quarterly Other financing activities fell 76.74% year-over-year to $30000.0 in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $111000.0 (down 63.25% YoY) and the FY2025 annual result came in at $156000.0, down 3.11% from the prior year.
- Other financing activities retreated to $30000.0 in Q1 2026 per HBIO's latest filing, from $57000.0 in the prior quarter.
- Across five years, Other financing activities topped out at $461000.0 in Q4 2022 and bottomed at -$451000.0 in Q4 2023.
- The 5-year median for Other financing activities is $129000.0 (2025), against an average of $122076.9.
- The widest annual swing landed in 2023, when Other financing activities tumbled 197.83%; it then jumped 174.47% in 2025.
- Tracing HBIO's Other financing activities over 5 years: stood at $461000.0 in 2022, then plunged by 197.83% to -$451000.0 in 2023, then soared by 135.7% to $161000.0 in 2024, then slumped by 64.6% to $57000.0 in 2025, then tumbled by 47.37% to $30000.0 in 2026.
- Per Business Quant, the three latest HBIO Other financing activities figures stand at $30000.0 (Q1 2026), $57000.0 (Q4 2025), and $24000.0 (Q3 2025).
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Intuitive Surgical | 156.17 Bn | 151.78 Bn | 1.83 Bn |
| 2 | Becton Dickinson | 41.51 Bn | 40.49 Bn | 2.15 Bn |
| 3 | Resmed | 30.43 Bn | 28.77 Bn | 890.98 Mn |
| 4 | West Pharmaceutical Services | 22.78 Bn | 22.26 Bn | 296.40 Mn |
| 5 | Solventum | 13.39 Bn | 13.39 Bn | 1.10 Bn |
| 6 | Cooper Companies | 12.33 Bn | 12.20 Bn | 695.20 Mn |
| 7 | Align Technology | 11.65 Bn | 10.59 Bn | 736.59 Mn |
| 8 | Baxter International | 9.81 Bn | 7.77 Bn | 891.00 Mn |
| 9 | Aptargroup | 7.39 Bn | 7.19 Bn | 351.91 Mn |
| 10 | Harvard Bioscience | 25.38 Mn | 18.29 Mn | 12.24 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 30,000.00 |
| Mar 31, 2026 | 30,000.00 |
| Dec 31, 2025 | 57,000.00 |
| Dec 31, 2025 | 57,000.00 |
| Sep 30, 2025 | 24,000.00 |
| Sep 30, 2025 | 24,000.00 |
| Mar 31, 2025 | 129,000.00 |
| Mar 31, 2025 | 129,000.00 |
| Sep 30, 2024 | 161,000.00 |
| Sep 30, 2024 | 161,000.00 |
| Jun 30, 2024 | 12,000.00 |
| Jun 30, 2024 | 12,000.00 |
| Mar 31, 2024 | 47,000.00 |
| Mar 31, 2024 | 47,000.00 |
| Dec 31, 2023 | -451,000.00 |
| Dec 31, 2023 | -451,000.00 |
| Jun 30, 2023 | 295,000.00 |
| Jun 30, 2023 | 295,000.00 |
| Mar 31, 2023 | 156,000.00 |
| Mar 31, 2023 | 156,000.00 |
| Dec 31, 2022 | 461,000.00 |
| Dec 31, 2022 | 461,000.00 |
| Sep 30, 2022 | 387,000.00 |
| Sep 30, 2022 | 387,000.00 |
| Jun 30, 2022 | 279,000.00 |
| Jun 30, 2022 | 279,000.00 |
| Dec 31, 2021 | 3.41 Mn |
| Dec 31, 2021 | 3.41 Mn |
| Sep 30, 2021 | 1.66 Mn |
| Sep 30, 2021 | 1.66 Mn |
| Jun 30, 2021 | 526,000.00 |
| Jun 30, 2021 | 526,000.00 |
| Mar 31, 2021 | 101,000.00 |
| Mar 31, 2021 | 101,000.00 |
| Dec 31, 2020 | 416,000.00 |
| Dec 31, 2020 | 416,000.00 |
| Sep 30, 2020 | 620,000.00 |
| Sep 30, 2020 | 620,000.00 |
| Jun 30, 2020 | 20,000.00 |
| Jun 30, 2020 | 20,000.00 |
| Mar 31, 2020 | 242,000.00 |
| Mar 31, 2020 | 242,000.00 |
| Dec 31, 2019 | 5,000.00 |
| Dec 31, 2019 | 5,000.00 |
| Sep 30, 2019 | 128,000.00 |
| Sep 30, 2019 | 128,000.00 |
| Jun 30, 2019 | 2,000.00 |
| Jun 30, 2019 | 2,000.00 |
| Mar 31, 2019 | 429,000.00 |
| Mar 31, 2019 | 429,000.00 |
| Dec 31, 2018 | 39,000.00 |
| Dec 31, 2018 | 39,000.00 |
| Sep 30, 2018 | 39,000.00 |
| Sep 30, 2018 | 39,000.00 |
| Mar 31, 2018 | 1.93 Mn |
| Mar 31, 2018 | 1.93 Mn |
| Jun 30, 2015 | 32,000.00 |
| Jun 30, 2015 | 32,000.00 |
| Dec 31, 2013 | 604,000.00 |
| Dec 31, 2013 | 604,000.00 |